We are live on ! Find out more
KRRO icon

Korro Bio
KRRO

68 hedge funds and large institutions have $382M invested in Korro Bio in 2020 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 28 increasing their positions, 4 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

600% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 4

189% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 9

70% more capital invested

Capital invested by funds: $225M → $382M (+$157M)

33% more funds holding

Funds holding: 51 → 68 (+17)

0.25% more ownership

Funds ownership: 0.82% → 1.07% (+0.25%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
68
Holders Change
+17
Holders Change %
+33.33%
% of All Funds
1.39%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
26
Increased
28
Reduced
4
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$22.7M
2
WA
Wasatch Advisors
Utah
+$17M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$15.4M
4
State Street
State Street
Massachusetts
+$6.23M
5
Northern Trust
Northern Trust
Illinois
+$4.29M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$16.8M
2
BBA
Baker Bros. Advisors
New York
-$4.24M
3
Federated Hermes
Federated Hermes
Pennsylvania
-$1.05M
4
ECM
ExodusPoint Capital Management
New York
-$497K
5
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
-$305K
Name Holding Trade Value Shares
Change 		Change in
Stake
VOYA Investment Management
51
VOYA Investment Management
Georgia
$228K +$177K +196 New
UBS Group
52
UBS Group
Switzerland
$226K +$100K +111 +134%
MLICM
53
Metropolitan Life Insurance Company (MetLife)
New York
$209K +$163K +180 New
Legal & General Group
54
Legal & General Group
United Kingdom
$108K +$67.8K +75 +417%
Citigroup
55
Citigroup
New York
$90K +$37.9K +42 +120%
GFPC
56
Global Financial Private Client
Florida
$67.7K – – –
AIP
57
Ameritas Investment Partners
Nebraska
$58K +$36.1K +40 +400%
TRCT
58
Tower Research Capital (TRC)
New York
$56K +$44.3K +49 New
Bank of Montreal
59
Bank of Montreal
Ontario, Canada
$51K +$40.7K +45 New
SO
60
STRS Ohio
Ohio
$34K – – –
FC
61
FORA Capital
Florida
$30K +$23.5K +26 New
RA
62
Royce & Associates
New York
$29K +$22.6K +25 New
BG
63
Bollard Group
Massachusetts
$26K +$19.9K +22 New
Royal Bank of Canada
64
Royal Bank of Canada
Ontario, Canada
$21K +$1.81K +2 +13%
CHA
65
Carmichael Hill & Associates
Maryland
$6K – – –
PAG
66
Private Advisor Group
New Jersey
$2K +$903 +1 New
KFS
67
Kelly Financial Services
Massachusetts
$1.63K – – –
PAM
68
Panagora Asset Management
Massachusetts
$1K – – –
DM
69
Deerfield Management
New York
– -$16.8M -18,914 Closed
ECM
70
ExodusPoint Capital Management
New York
– -$497K -558 Closed
Qube Research & Technologies (QRT)
71
Qube Research & Technologies (QRT)
United Kingdom
– -$305K -343 Closed
Millennium Management
72
Millennium Management
New York
– -$273K -306 Closed
Victory Capital Management
73
Victory Capital Management
Texas
– -$162K -181 Closed
MWNA
74
Marshall Wace North America
New York
– -$93K -104 Closed
BII
75
Bainco International Investors
Massachusetts
– -$71K -80 Closed
1 2
3
4

KRRO Hedge Fund Activity: Q2 2020 in Review

68 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Korro Bio (KRRO) for Q2 2020, worth a combined $382M — up 70% from $225M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new KRRO positions and 9 closed out — a net gain of 17 holders — while 28 added to existing stakes and 4 trimmed.

The largest buyer was BlackRock, adding an estimated $22.7M. The largest seller was Deerfield Management, exiting entirely with an estimated $16.8M sold.

  • 68 institutional investors held Korro Bio (KRRO) as of Q2 2020, up from 51 in Q1 2020.
  • Funds reported $382M of Korro Bio stock for Q2 2020, up 70% quarter-over-quarter.
  • 26 funds opened new Korro Bio positions in Q2 2020 and 9 closed out, a net change of +17 holders.
  • The largest Korro Bio buyer in Q2 2020 was BlackRock, an estimated $22.7M added.
  • The largest Korro Bio seller in Q2 2020 was Deerfield Management, an estimated $16.8M sold.

Based on aggregated 13F filings for Q2 2020.